Eosinophils pp 53-70 | Cite as

Cell Signalling During Human Eosinophil Differentiation

  • Miranda BuitenhuisEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1178)


Eosinophil differentiation is a complex series of events regulated by cytokines at multiple levels, including proliferation, survival, and maturation. The development of an ex vivo eosinophil differentiation model, using the current knowledge on factors involved in this process, has facilitated efforts to understand the molecular mechanisms underlying human eosinophil development. Differentiation of human hematopoietic progenitor cells, isolated by density centrifugation and immunomagnetic cell separation, towards mature eosinophils, involves a 17-day culture period in the presence of a mixture of cytokines. At early stages of differentiation, these cells can be retrovirally transduced resulting in modulation of the expression of genes of interest to examine their role in eosinophil development. Eosinophil maturation can be analyzed by combining three different methods: histochemical analysis, flow cytometric analysis, and Luxol Fast Blue staining. In addition to this ex vivo differentiation model, human hematopoietic progenitors can be transplanted into immune-deficient mice resulting in the development of all human hematopoietic lineages in the mouse bone marrow, including eosinophils. Although the ex vivo differentiation model can be used separately, combining it with the transplantation model will give insight into not only regulation of human eosinophil development but also hematopoiesis in general.

Key words

Human eosinophil differentiation Hematopoietic progenitors CD34 Retroviral transduction Flow cytometric analysis β2-Microglobulin (−/−) NOD/SCID mice Histochemical analysis 



The author thanks the current and past members of the departments of Respiratory Medicine and Immunology at the University Medical Center Utrecht (the Netherlands), the Department of Hematology at the Erasmus MC (the Netherlands), and the Hematopoietic Stem Cell Laboratory at the Lund Strategic Research Center for Stem Cell Biology and Cell Therapy in Sweden for helping develop these protocols.


  1. 1.
    Majeti R, Park CY, Weissman IL (2007) Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1(6):635–645, Pubmed: 18371405PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Hoebeke I, De Smedt M, Stolz F, Pike-Overzet K, Staal FJ, Plum J, Leclercq G (2007) T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34(+)CD38(-)CD7(+) common lymphoid progenitors expressing lymphoid-specific genes. Leukemia 21(2):311–319, Pubmed: 17170726PubMedCrossRefGoogle Scholar
  3. 3.
    Manz MG, Miyamoto T, Akashi K, Weissman IL (2002) Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A 99:11872–11877, Pubmed: 12193648PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Mori Y, Iwasaki H, Kohno K, Yoshimoto G, Kikushige Y, Okeda A, Uike N, Niiro H, Takenaka K, Nagafuji K, Miyamoto T, Harada M, Takatsu K, Akashi K (2009) Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor. J Exp Med 206(1):183–193, Pubmed: 19114669PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Sitnicka E, Buza-Vidas N, Larsson S et al (2003) Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood 102:881–886, Pubmed: 12676789PubMedCrossRefGoogle Scholar
  6. 6.
    Yamaguchi Y, Suda T, Suda J et al (1988) Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 167:43–56, Pubmed: 3257253PubMedCrossRefGoogle Scholar
  7. 7.
    Sanderson CJ, Warren DJ, Strath M (1985) Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J Exp Med 162:60–74PubMedCrossRefGoogle Scholar
  8. 8.
    Buitenhuis M, Baltus B, Lammers JW, Coffer PJ, Koenderman L (2003) Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. Blood 101(1):134–142, Pubmed: 12393707PubMedCrossRefGoogle Scholar
  9. 9.
    Buitenhuis M, Verhagen LP, Cools J, Coffer PJ (2007) Molecular mechanisms underlying FIP1L1-PDGFRA-mediated myeloproliferation. Cancer Res 67(8):3759–3766, Pubmed: 17440089PubMedCrossRefGoogle Scholar
  10. 10.
    Buitenhuis M, van Deutekom HW, Verhagen LP, Castor A, Jacobsen SE, Lammers JW, Koenderman L, Coffer PJ (2005) Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2. Blood 105(11):4272–4281, Pubmed: 15701714PubMedCrossRefGoogle Scholar
  11. 11.
    Ulfman LH, Kamp VM, van Aalst CW, Verhagen LP, Sanders ME, Reedquist KA, Buitenhuis M, Koenderman L (2008) Homeostatic intracellular-free Ca2+ is permissive for Rap1-mediated constitutive activation of alpha4 integrins on eosinophils. J Immunol 180(8):5512–5519, Pubmed: 18390735PubMedCrossRefGoogle Scholar
  12. 12.
    Buitenhuis M, Verhagen LP, van Deutekom HW, Castor A, Verploegen S, Koenderman L, Jacobsen SE, Coffer PJ (2008) Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis. Blood 111(1):112–121, Pubmed: 17890457PubMedCrossRefGoogle Scholar
  13. 13.
    Beekman JM, Verhagen LP, Geijsen N, Coffer PJ (2009) Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor output. Blood 114(18):3917–3927, Pubmed: 19654410PubMedCrossRefGoogle Scholar
  14. 14.
    Geest CR, Zwartkruis FJ, Vellenga E, Coffer PJ, Buitenhuis M (2009) Mammalian target of rapamycin activity is required for expansion of CD34+ hematopoietic progenitor cells. Haematologica 94(7):901–910, Pubmed: 19535348PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Geest CR, Buitenhuis M, Laarhoven AG, Bierings MB, Bruin MC, Vellenga E, Coffer PJ (2009) p38 MAP kinase inhibits neutrophil development through phosphorylation of C/EBPalpha on serine 21. Stem Cells 27(9):2271–2282, Pubmed: 19544470PubMedCrossRefGoogle Scholar
  16. 16.
    de Bruin AM, Buitenhuis M, van der Sluijs KF, van Gisbergen KP, Boon L, Nolte MA (2010) Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-gamma. Blood 116(14):2559–2569, Pubmed: 20587787PubMedCrossRefGoogle Scholar
  17. 17.
    Kollet O, Peled A, Byk T, Ben-Hur H, Greiner D, Shultz L, Lapidot T (2000) beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95(10):3102–3105, Pubmed: 10807775PubMedGoogle Scholar
  18. 18.
    Glimm H, Eisterer W, Lee K, Cashman J, Holyoake TL, Nicolini F, Shultz LD, von Kalle C, Eaves CJ (2001) Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest 107(2):199–206, Pubmed: 11160136PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Kikly KK, Bochner BS, Freeman SD, Tan KB, Gallagher KT, D’alessio KJ, Holmes SD, Abrahamson JA, Erickson-Miller CL, Murdock PR, Tachimoto H, Schleimer RP, White JR (2000) Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells and basophils. J Allergy Clin Immunol 105:1093–1100, Pubmed: 10856141PubMedCrossRefGoogle Scholar
  20. 20.
    Floyd H, Ni J, Cornish AL, Zeng Z, Liu D, Carter KC, Steel J, Crocker PR (2000) Siglec-8: a novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem 275:861–866, Pubmed: 10625619PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, New York 2014

Authors and Affiliations

  1. 1.Department of HematologyErasmus MCRotterdamThe Netherlands

Personalised recommendations